Search research articles
Contact Us
Filters
Showing results (191-200 of 395) with videos related to
Page
of 40
Sort By:
Alzheimer'S Research & Therapy
|
November 19, 2014
β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage
Erik Portelius, Robert A Dean, Ulf Andreasson, et al.
EMBO Molecular Medicine
|
November 12, 2019
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
Sebastian Palmqvist, Philip S Insel, Erik Stomrud, et al.
Psychoneuroendocrinology
|
March 12, 2013
Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease
Per Johansson, Daniel Åberg, Jan-Ove Johansson, et al.
Brain : a Journal of Neurology
|
October 17, 2020
Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease
Niklas Mattsson-Carlgren, Shorena Janelidze, Sebastian Palmqvist, et al.
Biochemical and Biophysical Research Communications
|
August 17, 2011
The N-terminal domain of α-dystroglycan, released as a 38 kDa protein, is increased in cerebrospinal fluid in patients with Lyme neuroborreliosis
Camilla Hesse, Inger Johansson, Niklas Mattsson, et al.
Brain : a Journal of Neurology
|
July 14, 2021
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease
Joana B Pereira, Shorena Janelidze, Ruben Smith, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 16, 2014
The transitional association between β-amyloid pathology and regional brain atrophy
Philip S Insel, Niklas Mattsson, Michael C Donohue, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Amanda Annettesdotter, Nicola Spotorno, Anika Wuestefeld, et al.
Neurology and Therapy
|
July 20, 2025
Clinical Performance of the Elecsys CSF pTau<sub>181</sub>/Aβ<sub>42</sub> Ratio for Concordance with Tau-PET in Two Independent Cohorts
Ruben Smith, Leslie Shaw, Sebastian Palmqvist, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Amanda Annettesdotter, Nicola Spotorno, Anika Wuestefeld, et al.
Page
of 40
Search research articles
Search
Showing results (191-200 of 395) with videos related to
Sort By:
Page
of 40
Alzheimer'S Research & Therapy
|
November 19, 2014
β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage
Erik Portelius, Robert A Dean, Ulf Andreasson, et al.
EMBO Molecular Medicine
|
November 12, 2019
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
Sebastian Palmqvist, Philip S Insel, Erik Stomrud, et al.
Psychoneuroendocrinology
|
March 12, 2013
Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease
Per Johansson, Daniel Åberg, Jan-Ove Johansson, et al.
Brain : a Journal of Neurology
|
October 17, 2020
Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease
Niklas Mattsson-Carlgren, Shorena Janelidze, Sebastian Palmqvist, et al.
Biochemical and Biophysical Research Communications
|
August 17, 2011
The N-terminal domain of α-dystroglycan, released as a 38 kDa protein, is increased in cerebrospinal fluid in patients with Lyme neuroborreliosis
Camilla Hesse, Inger Johansson, Niklas Mattsson, et al.
Brain : a Journal of Neurology
|
July 14, 2021
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease
Joana B Pereira, Shorena Janelidze, Ruben Smith, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 16, 2014
The transitional association between β-amyloid pathology and regional brain atrophy
Philip S Insel, Niklas Mattsson, Michael C Donohue, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Amanda Annettesdotter, Nicola Spotorno, Anika Wuestefeld, et al.
Neurology and Therapy
|
July 20, 2025
Clinical Performance of the Elecsys CSF pTau<sub>181</sub>/Aβ<sub>42</sub> Ratio for Concordance with Tau-PET in Two Independent Cohorts
Ruben Smith, Leslie Shaw, Sebastian Palmqvist, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Amanda Annettesdotter, Nicola Spotorno, Anika Wuestefeld, et al.
Page
of 40